The FDA cannot verify the quality, safety, or effectiveness of these non-FDA-approved compounded GLP-1 products Entities engaged in mass marketing should be on notice. FDA Press Announcement In regulatory language, the agency also made clear that compounded products cannot be marketed as generic, clinically proven, or equivalent to approved drugs
Jastreboff AM, Kaplan LM, Frias JP, Wu Q, Du Y, Gurbuz S, et al
Patients should also be aware of potential side effects, which may include local irritation or allergic reactions, although these are generally rare
Petersburg Institute of Bioregulation and Gerontology and has been shown to elongate telomeres in human somatic cells [1]
This increase is a notable portion of the total US prescription drug spending